Get started
Author

Maximilian Moos

Observed names: M Moos, M. Moos
Observed institutions: Leeds General Infirmary, United States Food and Drug Administration, Inserm, Johannes Gutenberg University Mainz, Heidelberg University, Southampton General Hospital, University Hospital Heidelberg, ETH Zurich, Centre Hospitalier Universitaire de Montpellier, University Medical Center of the Johannes Gutenberg University Mainz, Centre Hospitalier Universitaire de Nîmes, National Center for Tumor Diseases, Hôpital Lyon Sud, Établissement Français du Sang, Skåne University Hospital, Université Montpellier 1, Istituto Oncologico della Svizzera Italiana, University of Turin
ORCID: 0009-0002-1397-0682
Observed ORCID: 0009-0002-1397-0682
OpenAlex ID: A5111503052
The adhesion molecule on glia (AMOG) is a homologue of the beta subunit of the Na,K-ATPase.
1990 · S Gloor, H Antonicek, et al. · The Journal of Cell Biology · 357
CD200 is a new prognostic factor in multiple myeloma
2006 · J. Moreaux, D. Hose, et al. · Blood · 234
PDF
Structure of two human beta‐actin‐related processed genes one of which is located next to a simple repetitive sequence.
1983 · M. Moos, D. Gallwitz · The EMBO Journal · 166
Astrocyte-derived TGF-beta 2 and NGF differentially regulate neural recognition molecule expression by cultured astrocytes.
1991 · B Saad, D B Constam, et al. · The Journal of Cell Biology · 125
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma
2006 · K Mahtouk, F W Cremer, et al. · Oncogene · 105
Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma.
1994 · R Haas, M Moos, et al. · Journal of Clinical Oncology · 85
Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients
2009 · S Fruehauf, G Ehninger, et al. · Bone Marrow Transplantation · 69
Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)
2007 · M Hundemer, U Klein, et al. · Bone Marrow Transplantation · 66
High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
1996 · R Haas, M Moos, et al. · PubMed · 61
The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin’s lymphoma
1998 · M Moos, R Schulz, et al. · Leukemia · 54
TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines
2007 · J. Moreaux, D. Hose, et al. · Haematologica · 48
First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yield
1998 · K Kiel, FW Cremer, et al. · Bone Marrow Transplantation · 46
Variability of polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicentre study
1999 · P.W.M. Johnson, K. Swinbank, et al. · Annals of Oncology · 44
Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation
1999 · K Kiel, FW Cremer, et al. · Bone Marrow Transplantation · 39
A quantitative PCR assay for the detection of low amounts of malignant cells in multiple myeloma
1997 · F.W. Cremer, K. Kiel, et al. · Annals of Oncology · 32
PDF
Analysis of promoter activity and 5′ genomic structure of the neural cell adhesion molecule L1
1992 · A. Kohl, K. P. Giese, et al. · Journal of Neuroscience Research · 32
Leukapheresis products in multiple myeloma: lower tumor load after mobilization with cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) compared with G-CSF alone.
1998 · F W Cremer, K Kiel, et al. · PubMed · 31
Identification of a cDNA clone specific for the neural cell adhesion molecule AMOG
1989 · S. Pagliusi, H. Antonicek, et al. · Journal of Neuroscience Research · 29
Evaluation of the kinetics of the bone marrow tumor load in the course of sequential high-dose therapy assessed by quantitative PCR as a predictive parameter in patients with multiple myeloma
2000 · FW Cremer, E Ehrbrecht, et al. · Bone Marrow Transplantation · 22
Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation
2001 · C. Gemmel, F. Cremer, et al. · Annals of Hematology · 20
The gene encoding a Prevotella loescheii lectin-like adhesin contains an interrupted sequence which causes a frameshift
1992 · J N Manch-Citron, J Allen, et al. · Journal of Bacteriology · 19
Molecular monitoring of the tumor load predicts progressive disease in patients with multiple myeloma after high-dose therapy with autologous peripheral blood stem cell transplantation
2001 · E Lipinski, FW Cremer, et al. · Bone Marrow Transplantation · 18
The nucleotide sequences of the actin genes from Saccharomyces carlsbergensis and Saccharomyces cerevisiae are identical except for their introns.
1981 · W Nellen, C Donath, et al. · PubMed · 15
Bone marrow derived dendritic cells from patients with multiple myeloma cultured with three distinct protocols do not bear Kaposi's sarcoma associated herpesvirus DNA
1999 · F. Bellos, H. Goldschmidt, et al. · Annals of Oncology · 14
PDF
Molecular monitoring of tumour load kinetics predicts disease progression after non-myeloablative allogeneic stem cell transplantation in multiple myeloma
2005 · M.S. Raab, F.W. Cremer, et al. · Annals of Oncology · 13
Works count: 46
Citation count: 1,804
H-index: 20
I10-index: 29
Year
Topic
Type